Mergers & Acquisitions

Mergers & Acquisitions Law360 provides breaking news and analysis on high-impact mergers and acquisitions and the attorneys involved. Coverage includes major deals, related litigation and enforcement actions, and policy developments that affect corporate dealmaking.



Sign up for a 7-day FREE trial today!



Latest News in Mergers & Acquisitions

  • September 29, 2026

    AstraZeneca To Inject $2B In US Cancer Biopharma

    British giant AstraZeneca said Tuesday it will invest $2 billion in oncology specialist Summit Therapeutics and partner with the U.S. biopharmaceutical firm to boost its cancer treatment portfolio.

  • September 28, 2026

    SEC Says Couple Leaked Info Ahead Of $3.7B Cummins Deal

    The U.S. Securities and Exchange Commission announced settlements Monday with a former Cummins Inc. manager and her husband charged with disclosing details about the company's $3.7 billion Meritor acquisition to a chain of individuals who reaped over $500,000 from the inside information.

  • September 28, 2026

    3 Firms Lead $663.7M Lifecore Biomedical Take-Private Deal

    Lifecore Biomedical Inc. on Monday unveiled plans to become a private company after it is bought by private equity shop Webster Equity Partners in a deal valued at up to $663.7 million that was built by three law firms.

  • September 28, 2026

    Nextdoor, Khosla Say Investor Brought De-SPAC Suit Too Late

    Nextdoor and Khosla Ventures urged the Delaware Chancery Court on Monday to dismiss a stockholder lawsuit challenging Nextdoor's de-SPAC merger as untimely, arguing the clock began running when the proxy that an investor described as misleading was issued in October 2021, while the plaintiff insisted later disclosures and tolling doctrines keep her claims alive.

  • September 28, 2026

    Lantheus Investor Asks Court To Halt 'Unfair' $8B Curium Deal

    A Lantheus Holdings Inc. investor wants a Massachusetts state judge to block its $8 billion take-private deal with fellow radiopharmaceutical company Curium in its current form, calling the deal "fundamentally unfair" to shareholders.

See more Mergers & Acquisitions news

Mergers & Acquisitions

Areas of Coverage

  • TRANSACTIONS
  • Mergers and acquisitions valued at $100MM or more
  • Company spinoffs and splitups
  • Transactions involving stakes of $100MM or more
  • Hostile takeovers and leveraged buyouts
  • Poison pill implementation
  • Bankruptcy selloffs
  • AGENCIES
  • Financial Industry Regulatory Authority
  • Federal Trade Commission
  • U.S. Department of Justice
  • POLICY & REGULATION
  • Dodd-Frank Act
  • International banking legislation and regulation
  • ENFORCEMENT
  • Merger reviews
  • Second requests
  • Challenges and divestitures
  • LITIGATION
  • Antitrust suits
  • Bankruptcy proceedings
  • Shareholder disputes
  • Corporate governance fights
  • Proxy battles and hostile takeover suits
  • Poison pill challenges
  • PROFILES
  • Personnel moves
  • Profiles of mergers and acquisitions practices

Readership

  • Mergers and acquisitions lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals